Treating obesity using glucagon-like peptide-1-directed N-methyl-D-aspartate receptor inhibition Post author: Post published: May 20, 2024 Post category:uncategorized Bimodal drug that successfully cures obesity, hyperglycemia, and dyslipidemia in mouse models. You Might Also Like Gene therapy to prevent stillbirth and premature delivery developed December 12, 2024 How to make a high-deductible health plan work for you April 13, 2026 NIH awards $3.9 million grant to develop a non-opioid pain treatment May 4, 2026